Chimera Investment Corp (CIM) concluded trading on Wednesday at a closing price of $14.09, with 0.48 million shares of worth about $6.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.53% during that period and on January 08, 2025 the price saw a loss of about -0.35%. Currently the company’s common shares owned by public are about 80.88M shares, out of which, 78.35M shares are available for trading.
Stock saw a price change of 0.64% in past 5 days and over the past one month there was a price change of -4.21%. Year-to-date (YTD), CIM shares are showing a performance of 0.64% which decreased to -6.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.28 but also hit the highest price of $16.89 during that period. The average intraday trading volume for Chimera Investment Corp shares is 521.69K. The stock is currently trading -2.41% below its 20-day simple moving average (SMA20), while that difference is down -4.36% for SMA50 and it goes to -0.81% lower than SMA200.
Chimera Investment Corp (NYSE: CIM) currently have 80.88M outstanding shares and institutions hold larger chunk of about 55.39% of that.
The stock has a current market capitalization of $1.14B and its 3Y-monthly beta is at 1.76. PE ratio of stock for trailing 12 months is 4.25, while it has posted earnings per share of $3.31 in the same period. It has a debt-to-equity ratio of 3.93. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CIM, volatility over the week remained 2.19% while standing at 2.42% over the month.
Analysts are in expectations that Chimera Investment Corp (CIM) stock would likely to be making an EPS of 0.38 in the current quarter, while forecast for next quarter EPS is 0.41 and it is 1.68 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.36 which is 0.42 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.39 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 15.25% while it is estimated to decrease by -4.46% in next year. EPS is likely to grow at an annualized rate of -2.54% for next 5-years, compared to annual growth of -35.15% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on December 06, 2023 offering a Neutral rating for the stock and assigned a target price of $5.50 to it. Coverage by Barclays stated Chimera Investment Corp (CIM) stock as an Underweight in their note to investors on December 10, 2020, suggesting a price target of $10 for the stock. On October 03, 2019, RBC Capital Mkts Initiated their recommendations, while on August 21, 2019, Credit Suisse Downgrade their ratings for the stock with a price target of $19.50. Stock get a Buy rating from Nomura on March 27, 2019.
